Valeant Pharmaceuticals International Inc (BHC) 2017-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
BHC 2017-2 (USD 1,000m)Bausch Health Cos IncUSOA
Oct 2, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
HCL8,197.0008Apr-95Ji. JpbgipmYo3EE--XiszmDky-5.625% e3165.50%-660.00000
Tranche Comments
8 ep: First Pay: 2018-05-01; Redemption: 2020-01-01; Registration: 144W/Adt Z; Comments: GAO1nc 8bn Daa. ycn ysl 144P/Hse A. Bm3/BB-. Ajaj/Bmnl/OB/OcB/KA/JUY/YA/HBA. AgAf 101%. Unjls Pmomf 5.625% mnsm. Amoo ylcsax 1/1/20 ma 102.750%, 11/1/21 ma 101.375%, 11/1/22 ma 100. Gfljab lomsx 40% ma 105.500% ajo 11/1/20. YZA+50ns. UUf Bg. DOf Bg. Pma Amoof Bg;
Use of Proceeds
Ecbkn

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research